from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv0916c/PE7

LFCtreatmentdescriptionclass of inhibitor

-0.679

Amikacinug/mL Amikacintranslation

-0.176

Cap5-10ug/mL Capreomycintranslation

-0.321

Rox10-50 ug/mL Roxithromycintranslation

-0.840

SM2-5 ug/mL Streptomycintranslation

-1.574

Tet5-10 ug/mL Tetracyclinetranslation

0.121

Rif0.2-5ug/mL Rifampicintranscription

-1.111

Rifp0.1-0.5ug/mL Rifapentinetranscription

1.107

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

1.089

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.132

CPZ10-50 ug/mL Chlorpromazinerespiration

-0.031

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.411

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

0.522

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

1.156

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

0.391

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.142

Econazole10-24 ug/mL Econazole (azole drug)respiration

-0.690

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-0.537

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

0.361

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.581

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

2.631

KCN5-20 ug/mL Potassium cyaniderespiration

0.127

NaN30.2-2 mM Sodium aziderespiration

-1.254

Nigericin50 uM Nigericinrespiration

-0.356

TRC10-150 ug/mL Triclosanrespiration

1.074

TRZ10-25 ug/mL Thioridazinerespiration

-1.079

Valinomycin0.5-10 uM Valinomycinrespiration

-0.405

ZnSO42 mM ZnSO4respiration

-0.447

menadione6-10 ug/mL Menadionerespiration

-0.954

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.507

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.401

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.566

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-0.921

NRP_1Non-replicating persistence stage 1dosRassociated

-0.392

Amp0.2mg/mL AmpicillincellWall

-0.320

Cephalexin20-100 ug/mL CephalexincellWall

-0.309

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.381

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.124

EMB10-20 ug/mL EthambutolcellWall

-0.803

Eta12-40 ug/mL EthionamidecellWall

-0.564

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.439

TLM0.1-0.2 mg/mL ThiolactomycincellWall

0.297

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.252

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

1.292

BZA0.12 mg/mL BenzamidearomaticAmides

0.798

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.814

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.331

H2O24 mM hydrogen peroxideDNAdamaging

0.305

Levo10 ug/mL LevofloxacinDNAdamaging

-0.181

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-0.424

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.346

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.194

UVUV-irradiationDNAdamaging

1.286

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.125

Antimycin12.5-50 ug/mL Antimycin A?

-1.368

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.970

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.769

PA_2110-50 ug/mL Antitubercular compound PA-21?

1.422

PA8240.2-2 ug/mL PA-824?

0.380

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.558

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-1.497

Verapamil50 uM Verapamil?

-0.596

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.602

methoxatin10-20 ug/mL Methoxatin?